Home
Log In
Shipping
Information
Contact Us
Advanced Search
DISEASES & HEALTH CONDITIONS->
GENERAL HEALTH->
MEDICAL & SURGICAL->
MEDICAL SPECIALTIES
->
MENTAL HEALTH->
NURSING->
NURSING EQUIPMENT
PHARMACEUTICAL->
VETERINARY->
CHARTS & MODELS
VOUCHERS
CLEARANCE TITLES
FEATURED PRODUCTS ...
Home
/
MEDICAL SPECIALTIES
/
Oncology
/
Systemic Treatment of Prostrate Cancer
Oncology
Product 210/240
Previous
Return to the Product List
Next
Systemic Treatment of Prostrate Cancer
larger image
ISBN 9780199561421
Author: HORWICH
Publ Date: 2010-03-19
Edition:
Binding: Paperback / softback
$78.26
Sale: $70.43
Save: 10% off
+ GST
Add to Cart:
Prostate cancer is one of the commonest cancers in men in the western world, and the prevalence is rising currently due to improvements in screening and treatment. Serum PSA represents a useful marker of disease. It has frequently a long natural history, creating the opportunities for multiple sequential therapeutic interventions. For patients with high risk local disease or with metastases, endocrine therapy is central to management. Hormone ablation has long
been the mainstay of endocrine therapy in this group of patients, though anti-androgens, oestrogens and corticosteroids can also cause remissions. In recent years effective and well-tolerated
chemotherapy regimens have been developed and evaluated. Docetaxel has an established role, and a range of biologically-targeted agents are in development.The dominant pattern of metastatic spread is to the axial skeleton and most symptomatic care is directed to palliation of bone pain. The role of bisphosphonates remains controversial, but bone-directed isotopes such as Strontium-89 are effective.Part of the Oxford Oncology Library, this pocketbook
summarises the up-to-date information on the use of systemic therapies in the management of prostate cancer (early stage, metastatic disease, and treatment of "biochemical" recurrence). With
contributions from leading oncologists from both Europe and the USA, the book provides a practical guide to the range of endocrine and cytotoxic therapies currently available to clinicians, as well as to other palliative anticancer strategies, and will be valuable to all health professionals involved in the management of patients with prostate cancer.
Whilst every effort is made to keep pricing information up-to-date, prices and availability are subject to change without notice. Where prices or other details have changed from those listed on the website we will contact the customer and only proceed with the order after receiving acceptance of the revised pricing.
Systemic Treatment of Prostrate Cancer
Home
Your IP Address is: 3.22.70.169
Copyright © 2024
Medical Books
. Powered by
Zen Cart